InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Europe issues biosimilar-friendly guidelines


Guidelines for the production of biosimilar antibody drugs in Europe released last week focused on safety rather than efficacy, setting a lower hurdle than had been feared

The European Medicines Agency’s rules will require generic producers of antibody drugs to prove that their product is as effective and safe as the reference product.

They will not have to prove separately that the drug benefits users, as...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements